Your gateway to a free society
Article

"Risk Of Attack Is Too High": US Navy Refuses To Provide Escorts To Ships Transiting Hormuz Strait

"Risk Of Attack Is Too High": US Navy Refuses To Provide Escorts To Ships Transiting Hormuz Strait One week after Trump announced that the US would cover insurance for ships transiting the Strait of Hormuz, and would provide them with US navy escorts, Reuters reports that the US Navy has refused near-daily requests from the shipping industry for military escorts through the Strait of Hormuz since ​the start of the war on Iran, saying the risk of attacks is too high for now. The U.S. Navy has held regular ⁠briefings with...
Back

aboutLiberty Portal

Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Jul 13, 2026 / Jason Ditz
Destruction Continues in South Lebanon as Israel Again Stalls on Drawdown
Demolitions and shelling continue apace against southern Lebanon as Israeli occupation forces continue to show no signs of withdrawing, and officials suggested that the token pullbacks agreed to during the most recent “peace deal” are simply not going to happen. The “pilot zone” pullbacks were never meant to be more than a symbolic move to […]
Read more
May 2, 2026 / Tyler Durden
USSS Chief Says Hilton Site Was 'Set Up Perfectly,' Critics Disagree
USSS Chief Says Hilton Site Was 'Set Up Perfectly,' Critics Disagree Authored by Susan Crabtree via RealClearPolitics, The head of the U.S. Secret Service is defending security arrangements at last Saturday’s White House Correspondents’ Association dinner, saying he would not change a thing about the security plan, even as questions continue to swirl around the shooting and his leadership of the agency. “The site was set up perfectly, I will tell you I would not change the site again,” Secret Service Director Sean Curran told Fox News host Will Cain Thursday. Curran said...
Read more
May 21, 2026 / Tyler Durden
Lilly's Next-Gen Weight-Loss Drug Clears Trial With Near-Bariatric Surgery Results
Lilly's Next-Gen Weight-Loss Drug Clears Trial With Near-Bariatric Surgery Results Eli Lilly reported positive Phase 3 results for its next-generation obesity drug, retatrutide, which delivered weight-loss results on par with those of bariatric surgery. In the TRIUMPH-1 trial, overweight adults, but without diabetes, achieved meaningful weight loss across all tested doses after 80 weeks: 12 mg dose: average weight loss of 70.3 pounds, or 28.3% of body weight. 9 mg dose: average weight loss of 64.4 pounds, or 25.9%. 4 mg dose: average weight loss of 47.2 pounds, or 19% Ahead of the results,...
Read more

support

If you like what we do and want to support us, then you are a fine humanitarian. Click the link below to find out more.

Support the liberty movement